The vaginal and gastrointestinal microbiomes in gynecologic cancers: A review of applications in etiology, symptoms and treatment

Gynecologic Oncology

Volumn 138, Issue 1, 2015, Pages 190-200

  Chase, Dana ^a   Goulder, Alison ^b   Zenhausern, Frederic ^b   Monk, Bradley ^a   Herbst Kralovetz, Melissa ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial therapeutics; Commensal microbiota; Dysbiosis; Epithelial barrier function; Probiotics; Quality of life; Radiation and chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; PROBIOTIC AGENT; SEX HORMONE;

CACHEXIA; CANCER CHEMOTHERAPY; CANCER THERAPY; CARCINOGENESIS; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL (TOPIC); CYSTITIS; DISEASE ASSOCIATION; FEMALE; FEMALE GENITAL SYSTEM; FEMALE GENITAL TRACT CANCER; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; OBESITY; OVARY CANCER; PAPILLOMAVIRUS INFECTION; PELVIC INFLAMMATORY DISEASE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RADIATION ENTEROPATHY; RADIATION INDUCED CYSTITIS; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA ATROPHY; VAGINA FLORA; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TRACT; MICROBIOLOGY; MICROFLORA; VAGINA;

FEMALE; GASTROINTESTINAL TRACT; GENITAL NEOPLASMS, FEMALE; HUMANS; MICROBIOTA; VAGINA;

EID: 84931568592     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.04.036     Document Type: Review

References (87)

1. J. Ravel, P. Gajer, Z. Abdo, G.M. Schneider, S.S. Koenig, and S.L. McCulle Vaginal microbiome of reproductive-age women Proc. Natl. Acad. Sci. U. S. A. 108 Suppl. 1 2011 4680 4687
2. K. Jaaback, N. Johnson, and T.A. Lawrie Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer Cochrane Database Syst. Rev. 11 2011 CD005340
3. B. Ma, L.J. Forney, and J. Ravel Vaginal microbiome: rethinking health and disease Annu. Rev. Microbiol. 66 2012 371 389
4. S. Balzer, K. Malde, A. Lanzen, A. Sharma, and I. Jonassen Characteristics of 454 pyrosequencing data - enabling realistic simulation with flowsim Bioinformatics 26 18 2010 i420 i425
5. J.M. Janda, and S.L. Abbott 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls J. Clin. Microbiol. 45 9 2007 2761 2764
6. M.M. Kosiewicz, A.L. Zirnheld, and P. Alard Gut microbiota, immunity, and disease: a complex relationship Front. Microbiol. 2 2011 180
7. E. Holmes, J.V. Li, T. Athanasiou, H. Ashrafian, and J.K. Nicholson Understanding the role of gut microbiome-host metabolic signal disruption in health and disease Trends Microbiol. 19 7 2011 349 359
8. R.F. Schwabe, and C. Jobin The microbiome and cancer Nat. Rev. Cancer 13 11 2013 800 812
9. D.M. Chase, J. Kauderer, L. Wenzel, L. Ramondetta, D. Cella, and H.J. Long 3rd Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group Trials 179 and 204 Int. J. Gynecol. Cancer 25 2 2015 303 308
10. M.D. Agito, A. Atreja, and M.K. Rizk Fecal microbiota transplantation for recurrent C. difficile infection: ready for prime time? Cleve. Clin. J. Med. 80 2 2013 101 108
11. S. Ramakrishnan, S. Partricia, and G. Mathan Overview of high-risk HPV's 16 and 18 infected cervical cancer: pathogenesis to prevention Biomed. Pharmacother. 70 2015 103 110
12. R.M. Brotman, M.D. Shardell, P. Gajer, J.K. Tracy, J.M. Zenilman, and J. Ravel Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection J. Infect. Dis. 210 11 2014 1723 1733
13. W. Gao, J. Weng, Y. Gao, and X. Chen Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study BMC Infect. Dis. 13 2013 271
14. M.A. Clarke, A.C. Rodriguez, J.C. Gage, R. Herrero, A. Hildesheim, and S. Wacholder A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection BMC Infect. Dis. 12 2012 33
15. J.E. Lee, S. Lee, H. Lee, Y.M. Song, K. Lee, and M.J. Han Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort PLoS ONE 8 5 2013 e63514
16. J. Andreyev Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 54 8 2005 1051 1054
17. J. Abayomi, J. Kirwan, and A. Hackett The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life Eur. J. Oncol. Nurs. 13 4 2009 262 267
18. Y.D. Nam, H.J. Kim, J.G. Seo, S.W. Kang, and J.W. Bae Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing PLoS ONE 8 12 2013 e82659
19. G. Musso, R. Gambino, and M. Cassader Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 33 10 2010 2277 2284
20. J. Strauss, G.G. Kaplan, P.L. Beck, K. Rioux, R. Panaccione, and R. Devinney Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host Inflamm. Bowel Dis. 17 9 2011 1971 1978
21. G.N. Verne, M.E. Robinson, L. Vase, and D.D. Price Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients Pain 105 1-2 2003 223 230
22. E.E. Ustinova, D.W. Gutkin, and M.A. Pezzone Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides Am. J. Physiol. Renal Physiol. 292 1 2007 F123 F130
23. C. Manichanh, L. Rigottier-Gois, E. Bonnaud, K. Gloux, E. Pelletier, and L. Frangeul Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach Gut 55 2 2006 205 211
24. E.A. Mayer Gut feelings: the emerging biology of gut-brain communication Nat. Rev. Neurosci. 12 8 2011 453 466
25. D.J. Klumpp, and C.N. Rudick Summation model of pelvic pain in interstitial cystitis Nat. Clin. Pract. Urol. 5 9 2008 494 500
26. K. Bergmark, E. Avall-Lundqvist, P.W. Dickman, L. Henningsohn, and G. Steineck Vaginal changes and sexuality in women with a history of cervical cancer N. Engl. J. Med. 340 18 1999 1383 1389
27. H.P. Greenwald, and R. McCorkle Sexuality and sexual function in long-term survivors of cervical cancer J. Womens Health (Larchmt) 17 6 2008 955 963
28. H. Sharma, R. Tal, N.A. Clark, and J.H. Segars Microbiota and pelvic inflammatory disease Semin. Reprod. Med. 32 1 2014 43 49
29. R.B. Ness, K.E. Kip, S.L. Hillier, D.E. Soper, C.A. Stamm, and R.L. Sweet A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease Am. J. Epidemiol. 162 6 2005 585 590
30. E.E. Calle, and R. Kaaks Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat. Rev. Cancer 4 8 2004 579 591
31. P.J. Turnbaugh, M. Hamady, T. Yatsunenko, B.L. Cantarel, A. Duncan, and R.E. Ley A core gut microbiome in obese and lean twins Nature 457 7228 2009 480 484
32. R. Jumpertz, D.S. Le, P.J. Turnbaugh, C. Trinidad, C. Bogardus, and J.I. Gordon Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans Am. J. Clin. Nutr. 94 1 2011 58 65
33. R.M. Brotman, M.D. Shardell, P. Gajer, D. Fadrosh, K. Chang, and M.I. Silver Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy Menopause 21 5 2014 450 458
34. C.S. Plottel, and M.J. Blaser Microbiome and malignancy Cell Host Microbe 10 4 2011 324 335
35. D. Xu, T.H. Lin, C.R. Yeh, M.A. Cheng, L.M. Chen, and C. Chang The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth Biomed. Res. Int. 2014 2014 713263
36. C.M. Antunes, P.D. Strolley, N.B. Rosenshein, J.L. Davies, J.A. Tonascia, and C. Brown Endometrial cancer and estrogen use. Report of a large case-control study N. Engl. J. Med. 300 1 1979 9 13
37. D. Grady, T. Gebretsadik, K. Kerlikowske, V. Ernster, and D. Petitti Hormone replacement therapy and endometrial cancer risk: a meta-analysis Obstet. Gynecol. 85 2 1995 304 313
38. H.E. Dinkelspiel, J.D. Wright, S.N. Lewin, and T.J. Herzog Contemporary clinical management of endometrial cancer Obstet. Gynecol. Int. 2013 2013 583891
39. S. Ye, J. Yang, D. Cao, J. Lang, and K. Shen A systematic review of quality of life and sexual function of patients with cervical cancer after treatment Int. J. Gynecol. Cancer 24 7 2014 1146 1157
40. R. Hummelen, J.M. Macklaim, J.E. Bisanz, J.A. Hammond, A. McMillan, and R. Vongsa Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness PLoS ONE 6 11 2011 e26602
41. B.A. Goff, L.S. Mandel, C.W. Drescher, N. Urban, S. Gough, and K.M. Schurman Development of an ovarian cancer symptom index: possibilities for earlier detection Cancer 109 2 2007 221 227
42. B.A. Goff, L.S. Mandel, C.H. Melancon, and H.G. Muntz Frequency of symptoms of ovarian cancer in women presenting to primary care clinics JAMA 291 22 2004 2705 2712
43. B.A. Goff, L. Mandel, H.G. Muntz, and C.H. Melancon Ovarian carcinoma diagnosis Cancer 89 10 2000 2068 2075
44. L.B. Wenzel, H.Q. Huang, D.K. Armstrong, J.L. Walker, D. Cella, and G. Gynecologic Oncology Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study J. Clin. Oncol. 25 4 2007 437 443
45. L. Minig, J.I. Velez, E.L. Trimble, R. Biffi, A. Maggioni, and D.D. Jeffery Changes in short-term health-related quality of life in women undergoing gynecologic oncologic laparotomy: an associated factor analysis Support Care Cancer 21 3 2013 715 726
46. E.M. Poole, I.M. Lee, P.M. Ridker, J.E. Buring, S.E. Hankinson, and S.S. Tworoger A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor alpha receptor 2 levels and risk of ovarian cancer Am. J. Epidemiol. 178 8 2013 1256 1264
47. M.A. Krohn, S.L. Hillier, R.P. Nugent, M.F. Cotch, J.C. Carey, and R.S. Gibbs The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group J. Infect. Dis. 171 6 1995 1475 1480
48. H.M. Silver, R.S. Sperling, P.J. St Clair, and R.S. Gibbs Evidence relating bacterial vaginosis to intraamniotic infection Am. J. Obstet. Gynecol. 161 3 1989 808 812
49. S.L. Hillier, M.A. Krohn, E. Cassen, T.R. Easterling, L.K. Rabe, and D.A. Eschenbach The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes Clin. Infect. Dis. 20 Suppl. 2 1995 S276 S278
50. S.L. Hillier, N.B. Kiviat, S.E. Hawes, M.B. Hasselquist, P.W. Hanssen, and D.A. Eschenbach Role of bacterial vaginosis-associated microorganisms in endometritis Am. J. Obstet. Gynecol. 175 2 1996 435 441
51. N.B. Kiviat, P. Wolner-Hanssen, D.A. Eschenbach, J.N. Wasserheit, J.A. Paavonen, and T.A. Bell Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis Am. J. Surg. Pathol. 14 2 1990 167 175
52. C.M. Mitchell, A. Haick, E. Nkwopara, R. Garcia, M. Rendi, and K. Agnew Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women Am. J. Obstet. Gynecol. 212 5 2015 611.e1 611.e9
53. A.A. Tone, S. Salvador, S.J. Finlayson, A.V. Tinker, J.S. Kwon, and C.H. Lee The role of the fallopian tube in ovarian cancer Clin. Adv. Hematol. Oncol. 10 5 2012 296 306
54. Y. Malayev, R. Levene, and F. Gonzalez Palliative chemotherapy for malignant ascites secondary to ovarian cancer Am. J. Hosp. Palliat. Care 29 7 2012 515 521
55. S. Viaud, F. Saccheri, G. Mignot, T. Yamazaki, R. Daillere, and D. Hannani The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide Science 342 6161 2013 971 976
56. N. Iida, A. Dzutsev, C.A. Stewart, L. Smith, N. Bouladoux, and R.A. Weingarten Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment Science 342 6161 2013 967 970
57. N. Balogun, A. Forbes, M. Widschwendter, and A. Lanceley Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction Int. J. Gynecol. Cancer 22 6 2012 1089 1095
58. G.L. Klein, B.W. Petschow, A.L. Shaw, and E. Weaver Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target Curr. Opin. Support. Palliat. Care 7 4 2013 361 367
59. L.B. Bindels, and N.M. Delzenne Muscle wasting: the gut microbiota as a new therapeutic target? Int. J. Biochem. Cell Biol. 45 10 2013 2186 2190
60. J.H. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi, and B.J. Petrof Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin Infect. Immun. 74 12 2006 6829 6838
61. M.J. Tisdale Biology of cachexia J. Natl. Cancer Inst. 89 23 1997 1763 1773
62. L.B. Bindels, R. Beck, O. Schakman, J.C. Martin, F. De Backer, and F.M. Sohet Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model PLoS ONE 7 6 2012 e37971
63. P. Delia, G. Sansotta, V. Donato, P. Frosina, G. Messina, and C. De Renzis Use of probiotics for prevention of radiation-induced diarrhea World J. Gastroenterol. 13 6 2007 912 915
64. I. Chitapanarux, T. Chitapanarux, P. Traisathit, S. Kudumpee, E. Tharavichitkul, and V. Lorvidhaya Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients Radiat. Oncol. 5 2010 31
65. M. Demers, A. Dagnault, and J. Desjardins A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation Clin. Nutr. 33 5 2014 761 767
66. J. Giralt, J.P. Regadera, R. Verges, J. Romero, I. de la Fuente, and A. Biete Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial Int. J. Radiat. Oncol. Biol. Phys. 71 4 2008 1213 1219
67. V.L. Yarbrough, S. Winkle, and M.M. Herbst-Kralovetz Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications Hum. Reprod. Update 21 3 2015 353 377
68. J.M. Macklaim, C.R. Cohen, G. Donders, G.B. Gloor, J.E. Hill, and G.P. Parham Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease Reprod. Sci. 19 11 2012 1154 1162
69. J. Li, W. Wang, S.X. Xu, N.A. Magarvey, and J.K. McCormick Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci Proc. Natl. Acad. Sci. U. S. A. 108 8 2011 3360 3365
70. A. McMillan, M. Dell, M.P. Zellar, S. Cribby, S. Martz, and E. Hong Disruption of urogenital biofilms by lactobacilli Colloids Surf. B: Biointerfaces 86 1 2011 58 64
71. R. Hummelen, J. Changalucha, N.L. Butamanya, A. Cook, J.D. Habbema, and G. Reid Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV Int. J. Gynaecol. Obstet. 111 3 2010 245 248
72. A.E. Stapleton, M. Au-Yeung, T.M. Hooton, D.N. Fredricks, P.L. Roberts, and C.A. Czaja Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection Clin. Infect. Dis. 52 10 2011 1212 1217
73. H. Huang, L. Song, and W. Zhao Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials Arch. Gynecol. Obstet. 289 6 2014 1225 1234
74. K. Anukam, E. Osazuwa, I. Ahonkhai, M. Ngwu, G. Osemene, and A.W. Bruce Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial Microbes Infect. 8 6 2006 1450 1454
75. R.C. Martinez, S.A. Franceschini, M.C. Patta, S.M. Quintana, B.C. Gomes, and E.C. De Martinis Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial Can. J. Microbiol. 55 2 2009 133 138
76. P. Mastromarino, S. Macchia, L. Meggiorini, V. Trinchieri, L. Mosca, and M. Perluigi Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis Clin. Microbiol. Infect. 15 1 2009 67 74
77. W. Ya, C. Reifer, and L.E. Miller Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study Am. J. Obstet. Gynecol. 203 2 2010 (120 e1-6)
78. M.K. Cha, D.K. Lee, H.M. An, S.W. Lee, S.H. Shin, and J.H. Kwon Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16 BMC Med. 10 2012 72
79. E. Motevaseli, M. Shirzad, S.M. Akrami, A.S. Mousavi, A. Mirsalehian, and M.H. Modarressi Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate J. Med. Microbiol. 62 Pt 7 2013 1065 1072
80. V. Verhoeven, N. Renard, A. Makar, P. Van Royen, J.P. Bogers, and F. Lardon Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study Eur. J. Cancer Prev. 22 1 2013 46 51
81. L. Schlegel, S. Lemerle, and P. Geslin Lactobacillus species as opportunistic pathogens in immunocompromised patients Eur. J. Clin. Microbiol. Infect. Dis. 17 12 1998 887 888
82. M.H. Land, K. Rouster-Stevens, C.R. Woods, M.L. Cannon, J. Cnota, and A.K. Shetty Lactobacillus sepsis associated with probiotic therapy Pediatrics 115 1 2005 178 181
83. M.T. Liong Safety of probiotics: translocation and infection Nutr. Rev. 66 4 2008 192 202
84. M. Van den Nieuwboer, R.J. Brummer, F. Guarner, L. Morelli, M. Cabana, and E. Claasen The administration of probiotics and synbiotics in immune compromised adults: is it safe? Benefic. Microbes 6 1 2015 3 17
85. S.Y. Doerflinger, A.L. Throop, and M.M. Herbst-Kralovetz Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner J. Infect. Dis. 209 12 2014 1989 1999
86. L. Collado Yurrita, I. San Mauro Martin, M.J. Ciudad-Cabanas, M.E. Calle-Puron, and M. Hernandez Cabria Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials Nutr. Hosp. 30 n02 2014 244 252
87. A.C. Ford, E.M. Quigley, B.E. Lacy, A.J. Lembo, Y.A. Saito, and L.R. Schiller Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis Am. J. Gastroenterol. 109 10 2014 1547 1561